United States Injectable Anticoagulants Market Report 2016

October 2016 | 119 pages | ID: U0F5441A053EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Injectable Anticoagulants

Revenue, means the sales value of Injectable Anticoagulants

This report studies sales (consumption) of Injectable Anticoagulants in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Injectable Anticoagulants in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Injectable Anticoagulants Market Report 2016

1 INJECTABLE ANTICOAGULANTS OVERVIEW

1.1 Product Overview and Scope of Injectable Anticoagulants
1.2 Classification of Injectable Anticoagulants
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Injectable Anticoagulants
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Injectable Anticoagulants (2011-2021)
  1.4.1 United States Injectable Anticoagulants Sales and Growth Rate (2011-2021)
  1.4.2 United States Injectable Anticoagulants Revenue and Growth Rate (2011-2021)

2 UNITED STATES INJECTABLE ANTICOAGULANTS COMPETITION BY MANUFACTURERS

2.1 United States Injectable Anticoagulants Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Injectable Anticoagulants Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Injectable Anticoagulants Average Price by Manufactures (2015 and 2016)
2.4 Injectable Anticoagulants Market Competitive Situation and Trends
  2.4.1 Injectable Anticoagulants Market Concentration Rate
  2.4.2 Injectable Anticoagulants Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES INJECTABLE ANTICOAGULANTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Injectable Anticoagulants Sales and Market Share by Type (2011-2016)
3.2 United States Injectable Anticoagulants Revenue and Market Share by Type (2011-2016)
3.3 United States Injectable Anticoagulants Price by Type (2011-2016)
3.4 United States Injectable Anticoagulants Sales Growth Rate by Type (2011-2016)

4 UNITED STATES INJECTABLE ANTICOAGULANTS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Injectable Anticoagulants Sales and Market Share by Application (2011-2016)
4.2 United States Injectable Anticoagulants Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES INJECTABLE ANTICOAGULANTS MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Injectable Anticoagulants Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Injectable Anticoagulants Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Injectable Anticoagulants Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Injectable Anticoagulants Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Injectable Anticoagulants Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Injectable Anticoagulants Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Injectable Anticoagulants Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Injectable Anticoagulants Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Injectable Anticoagulants Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Injectable Anticoagulants Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 INJECTABLE ANTICOAGULANTS MANUFACTURING COST ANALYSIS

6.1 Injectable Anticoagulants Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Injectable Anticoagulants

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Injectable Anticoagulants Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Injectable Anticoagulants Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES INJECTABLE ANTICOAGULANTS MARKET FORECAST (2016-2021)

10.1 United States Injectable Anticoagulants Sales, Revenue Forecast (2016-2021)
10.2 United States Injectable Anticoagulants Sales Forecast by Type (2016-2021)
10.3 United States Injectable Anticoagulants Sales Forecast by Application (2016-2021)
10.4 Injectable Anticoagulants Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Injectable Anticoagulants
Table Classification of Injectable Anticoagulants
Figure United States Sales Market Share of Injectable Anticoagulants by Type in 2015
Table Application of Injectable Anticoagulants
Figure United States Sales Market Share of Injectable Anticoagulants by Application in 2015
Figure United States Injectable Anticoagulants Sales and Growth Rate (2011-2021)
Figure United States Injectable Anticoagulants Revenue and Growth Rate (2011-2021)
Table United States Injectable Anticoagulants Sales of Key Manufacturers (2015 and 2016)
Table United States Injectable Anticoagulants Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Injectable Anticoagulants Sales Share by Manufacturers
Figure 2016 Injectable Anticoagulants Sales Share by Manufacturers
Table United States Injectable Anticoagulants Revenue by Manufacturers (2015 and 2016)
Table United States Injectable Anticoagulants Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Injectable Anticoagulants Revenue Share by Manufacturers
Table 2016 United States Injectable Anticoagulants Revenue Share by Manufacturers
Table United States Market Injectable Anticoagulants Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Injectable Anticoagulants Average Price of Key Manufacturers in 2015
Figure Injectable Anticoagulants Market Share of Top 3 Manufacturers
Figure Injectable Anticoagulants Market Share of Top 5 Manufacturers
Table United States Injectable Anticoagulants Sales by Type (2011-2016)
Table United States Injectable Anticoagulants Sales Share by Type (2011-2016)
Figure United States Injectable Anticoagulants Sales Market Share by Type in 2015
Table United States Injectable Anticoagulants Revenue and Market Share by Type (2011-2016)
Table United States Injectable Anticoagulants Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Injectable Anticoagulants by Type (2011-2016)
Table United States Injectable Anticoagulants Price by Type (2011-2016)
Figure United States Injectable Anticoagulants Sales Growth Rate by Type (2011-2016)
Table United States Injectable Anticoagulants Sales by Application (2011-2016)
Table United States Injectable Anticoagulants Sales Market Share by Application (2011-2016)
Figure United States Injectable Anticoagulants Sales Market Share by Application in 2015
Table United States Injectable Anticoagulants Sales Growth Rate by Application (2011-2016)
Figure United States Injectable Anticoagulants Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Injectable Anticoagulants Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Injectable Anticoagulants Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Injectable Anticoagulants Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Injectable Anticoagulants Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Injectable Anticoagulants Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Injectable Anticoagulants Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Injectable Anticoagulants Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Injectable Anticoagulants Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Injectable Anticoagulants Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Injectable Anticoagulants Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Injectable Anticoagulants Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Injectable Anticoagulants
Figure Manufacturing Process Analysis of Injectable Anticoagulants
Figure Injectable Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Injectable Anticoagulants Major Manufacturers in 2015
Table Major Buyers of Injectable Anticoagulants
Table Distributors/Traders List
Figure United States Injectable Anticoagulants Production and Growth Rate Forecast (2016-2021)
Figure United States Injectable Anticoagulants Revenue and Growth Rate Forecast (2016-2021)
Table United States Injectable Anticoagulants Production Forecast by Type (2016-2021)
Table United States Injectable Anticoagulants Consumption Forecast by Application (2016-2021)